Literature DB >> 11339385

Neuropsychiatric disorders in the 22q11 deletion syndrome.

L Niklasson1, P Rasmussen, S Oskarsdóttir, C Gillberg.   

Abstract

PURPOSE: This study was undertaken with a view to establishing the occurrence of neuropsychiatric disorders in the 22q11 deletion syndrome.
METHODS: Thirty-two children and young adults with genetically confirmed 22q11 deletion were given comprehensive neuropsychiatric assessments.
RESULTS: Altogether, 56% had a neuropsychiatric disorder. Only 6% were of normal IQ and free of physchiatric disorder. Attention-deficit/hyperactivity disorder was diagnosed in 44% and 31% had an autism spectrum problem. In 16% criteria for both these diagnoses were met. Fifty-three percent had mental retardation, often with a test-profile suggesting a nonverbal learning disorder.
CONCLUSION: The findings imply that a majority of children and adolescents with 22q11 deletion syndrome are in need of neuropsychiatric assessment and intervention.

Entities:  

Mesh:

Year:  2001        PMID: 11339385     DOI: 10.1097/00125817-200101000-00017

Source DB:  PubMed          Journal:  Genet Med        ISSN: 1098-3600            Impact factor:   8.822


  44 in total

Review 1.  Association of genetic factors with selected measures of physical performance.

Authors:  William R Thompson; Stuart A Binder-Macleod
Journal:  Phys Ther       Date:  2006-04

Review 2.  A review of neurocognitive and behavioral profiles associated with 22q11 deletion syndrome: implications for clinical evaluation and treatment.

Authors:  Opal Ousley; Kimberly Rockers; Mary Lynn Dell; Karlene Coleman; Joseph F Cubells
Journal:  Curr Psychiatry Rep       Date:  2007-04       Impact factor: 5.285

3.  Prevalence of 22q11.2 deletions in 311 Dutch patients with schizophrenia.

Authors:  Mechteld L C Hoogendoorn; Jacob A S Vorstman; Gholam R Jalali; Jean-Paul Selten; Richard J Sinke; Beverly S Emanuel; René S Kahn
Journal:  Schizophr Res       Date:  2007-10-26       Impact factor: 4.939

Review 4.  Schizopsychotic symptom-profiles and biomarkers: beacons in diagnostic labyrinths.

Authors:  Tomas Palomo; Richard M Kostrzewa; Richard J Beninger; Trevor Archer
Journal:  Neurotox Res       Date:  2008-10       Impact factor: 3.911

Review 5.  Neural phenotypes of common and rare genetic variants.

Authors:  Carrie E Bearden; David C Glahn; Agatha D Lee; Ming-Chang Chiang; Theo G M van Erp; Tyrone D Cannon; Allan L Reiss; Arthur W Toga; Paul M Thompson
Journal:  Biol Psychol       Date:  2008-02-23       Impact factor: 3.251

6.  Neural substrates of inhibitory control deficits in 22q11.2 deletion syndrome.

Authors:  C A Montojo; M Jalbrzikowski; E Congdon; S Domicoli; C Chow; C Dawson; K H Karlsgodt; R M Bilder; C E Bearden
Journal:  Cereb Cortex       Date:  2013-10-31       Impact factor: 5.357

Review 7.  Converging levels of analysis on a genomic hotspot for psychosis: insights from 22q11.2 deletion syndrome.

Authors:  Matthew J Schreiner; Maria T Lazaro; Maria Jalbrzikowski; Carrie E Bearden
Journal:  Neuropharmacology       Date:  2012-10-23       Impact factor: 5.250

8.  Social impairments in chromosome 22q11.2 deletion syndrome (22q11.2DS): autism spectrum disorder or a different endophenotype?

Authors:  Kathleen Angkustsiri; Beth Goodlin-Jones; Lesley Deprey; Khyati Brahmbhatt; Susan Harris; Tony J Simon
Journal:  J Autism Dev Disord       Date:  2014-04

9.  Psychiatric disorders and autism in young children with 22q11.2 deletion syndrome compared to children with idiopathic autism.

Authors:  Yaffa Serur; Dafna Sofrin Frumer; Keren Daon; Dolly Sobol-Havia; Ronnie Weinberger; Cory Shulman; Doron Gothelf
Journal:  Eur Psychiatry       Date:  2018-11-16       Impact factor: 5.361

10.  Sex differences in the behavior of children with the 22q11 deletion syndrome.

Authors:  Christina Sobin; Karen Kiley-Brabeck; Samantha Hadley Monk; Jananne Khuri; Maria Karayiorgou
Journal:  Psychiatry Res       Date:  2009-02-14       Impact factor: 3.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.